There’s been a surge in demand for a class of diabetes drugs that are now popular for their serendipitous byproduct: weight loss. The drugs belong to a class called GLP-1 agonists and include semaglutide, the main ingredient in Ozempic, Wegovy, and Rybelsus; tirzepatide, which is found in Mounjaro; …